{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:47Z","timestamp":1793924507396,"version":"4.8.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejmech.2023.115699","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T09:49:24Z","timestamp":1690710564000},"page":"115699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds"],"prefix":"10.1016","volume":"259","author":[{"given":"S. Maheen","family":"Abdul Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder Singh","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Thareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-6241","authenticated-orcid":false,"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/eri.11.155","article-title":"Infectious diseases following natural disasters: prevention and control measures","volume":"10","author":"Kouadio","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115699_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00348-20","article-title":"Natural-product-based solutions for tropical infectious diseases","volume":"34","author":"Adegboye","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115699_bib3","series-title":"One Health for Veterinary Nurses and Technicians: an Introduction","first-page":"88","article-title":"Communicable diseases","author":"Barker","year":"2023"},{"key":"10.1016\/j.ejmech.2023.115699_bib4","series-title":"Phytochemistry, the Military and Health","first-page":"367","article-title":"Life-threatening diseases and conditions in the battlefield: pyrotherapeutic perspectives","author":"Botchie","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115699_bib5","series-title":"Plasmodium Species and Drug Resistance","article-title":"Plasmodium species and drug resistance","author":"Tseha","year":"2021"},{"issue":"7","key":"10.1016\/j.ejmech.2023.115699_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0965-1748(03)00067-5","article-title":"Exploring the salivary gland transcriptome and proteome of the Anopheles stephensi mosquito","volume":"33","author":"Valenzuela","year":"2003","journal-title":"Insect Biochemistry and Molecular Biology. Elsevier"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-022-04197-4","article-title":"Anopheles stephensi in Africa requires a more integrated response","volume":"21","author":"Mnzava","year":"2022","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115699_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ecy.3038","article-title":"The role of native and introduced birds in transmission of avian malaria in Hawaii","volume":"101","author":"McClure","year":"2020","journal-title":"Ecology"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03616","article-title":"Retrospective analysis of urban malaria cases due to Plasmodium falciparum and Plasmodium vivax: the case of Batu town, Oromia, Ethiopia","volume":"6","author":"Hassen","year":"2020","journal-title":"Heliyon"},{"issue":"10195","key":"10.1016\/j.ejmech.2023.115699_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(19)31097-9","article-title":"Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000\u201317: a spatial and temporal modelling study","volume":"394","author":"Weiss","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115699_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","article-title":"Plasmodium vivax: clinical spectrum, risk factors and pathogenesis","volume":"80","author":"Nicholas","year":"2012","journal-title":"Adv. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0972-9062.234620","article-title":"Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria","volume":"55","author":"Dayananda","year":"2018","journal-title":"J. Vector Borne Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13071-021-04797-0","article-title":"Global trend of Plasmodium malariae and Plasmodium ovale spp. malaria infections in the last two decades (2000\u20132020): a systematic review and meta-analysis","volume":"14","author":"Hawadak","year":"2021","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2023.115699_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CMR.00079-12","article-title":"Human infections and detection of Plasmodium knowlesi","volume":"26","author":"Singh","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115699_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijid.2020.11.177","article-title":"Significant symptoms and nonsymptom-related factors for malaria diagnosis in endemic regions of Indonesia","volume":"103","author":"Bria","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115699_bib17","unstructured":"World Health Organization (WHO), World Malaria Report 2022, Malaria by Numbers: Global and Regional Malaria Burden, WHO African Region."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115699_bib19","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1371\/journal.ppat.0030171","article-title":"Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature","volume":"3","author":"Baer","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2023.115699_bib20","series-title":"Biology, Malaria, Lifecycle","year":"2020"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/0255-0857.83906","article-title":"Drug resistance in malaria","volume":"29","author":"Parija","year":"2011","journal-title":"Indian J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12639-012-0174-4","article-title":"Immunological disturbances associated with malarial infection","volume":"37","author":"Pradhan","year":"2013","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ejmech.2023.115699_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12936-016-1391-6","article-title":"Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives","volume":"15","author":"Nevin","year":"2016","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12936-016-1577-y","article-title":"The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles","volume":"15","author":"Marrelli","year":"2016","journal-title":"Malar. J."},{"issue":"23","key":"10.1016\/j.ejmech.2023.115699_bib25","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.2174\/0929867324666170830103003","article-title":"New molecular targets and strategies for antimalarial discovery","volume":"26","author":"Aguiar","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib26","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1038\/s41598-017-09959-8","article-title":"Plasmodium falciparum GPCR-like receptor SR25 mediates extracellular K(+) sensing coupled to Ca(2+) signaling and stress survival","volume":"7","author":"Moraes","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115699_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.638869","article-title":"The knockout for G protein-coupled receptor-like PfSR25 increases the susceptibility of malaria parasites to the antimalarials lumefantrine and piperaquine but not to medicine for malaria venture compounds","volume":"12","author":"Santos","year":"2021","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib28","article-title":"Plasmodium falciparum CRK4 directs continuous rounds of DNA replication during schizogony","volume":"2","author":"Ganter","year":"2017","journal-title":"Nature Microbiology"},{"issue":"42","key":"10.1016\/j.ejmech.2023.115699_bib29","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3347\/kjp.2022.60.2.109","article-title":"Molecular markers for sulfadoxine\/pyrimethamine and chloroquine resistance in plasmodium falciparum in Thailand","volume":"60","author":"Kuesap","year":"2022","journal-title":"Kor. J. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/14756366.2020.1854244","article-title":"Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening","volume":"36","author":"Hoarau","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115699_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.6026\/97320630016672","article-title":"Molecular docking analysis of Plasmodium falciparum dihydroorotate dehydrogenase towards the design of effective inhibitors","volume":"16","author":"Owoloye","year":"2020","journal-title":"Bioinformation"},{"key":"10.1016\/j.ejmech.2023.115699_bib33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2016.09.085","article-title":"Dihydroorotate dehydrogenase: a drug target for the development of antimalarials","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib34","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1038\/s41467-022-33403-9","article-title":"A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13880209.2016.1225778","article-title":"In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria","volume":"55","author":"Wadood","year":"2017","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154022","article-title":"PI4-kinase and PfCDPK7 signaling regulate phospholipid biosynthesis in Plasmodium falciparum","volume":"23","author":"Maurya","year":"2022","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13065-022-00812-2","article-title":"Fragment-based virtual screening discovers potential new Plasmodium PI4KIII\u03b2 ligands","volume":"16","author":"Ibezim","year":"2022","journal-title":"BMC Chemistry"},{"issue":"387","key":"10.1016\/j.ejmech.2023.115699_bib39","doi-asserted-by":"crossref","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib40","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity","volume":"52","author":"Kerr","year":"2009","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115699_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1573409916666200701213526","article-title":"Combined CADD and virtual screening to identify novel nonpeptidic falcipain-2 inhibitors","volume":"17","author":"Rajguru","year":"2021","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14756366.2018.1564288","article-title":"Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone\u2013chalcone and isatin\u2013chalcone inhibitors probing the S2 active site pocket","volume":"34","author":"Allangba","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chembiol.2021.07.010","article-title":"Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention","volume":"29","author":"Summers","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1620\/tjem.211.99","article-title":"Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand","volume":"211","author":"Na-Bangchang","year":"2007","journal-title":"Tohoku J. Exp. Med."},{"issue":"7786","key":"10.1016\/j.ejmech.2023.115699_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115699_bib46","series-title":"Nature News and Views","author":"Tilley","year":"2019"},{"issue":"17","key":"10.1016\/j.ejmech.2023.115699_bib47","doi-asserted-by":"crossref","first-page":"E1759","DOI":"10.1073\/pnas.1322965111","article-title":"Diverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporter","volume":"111","author":"Summers","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115699_bib48","series-title":"PubChem Compound Summary for CID 24999143, Artefenomel","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib49","unstructured":"National Institute of Health, U. S. National Library of Medicine, ClinicalTrials.gov, Efficacy, Tolerability, PK of OZ439 in Adults with Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-Infection."},{"key":"10.1016\/j.ejmech.2023.115699_bib50","series-title":"PubChem Compound Summary for CID 44469321, Cipargamin","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib51","series-title":"ClinicalTrials.gov, A Study to Assess Efficacy, Safety of KAE609 in Adult Patients with Acute Malaria Mono-Infection","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115699_bib52","series-title":"PubChem Compound Summary for CID 53311393","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib53","series-title":"ClinicalTrials.gov, MMV390048 POC in Patients with P. Vivax and P. Falciparum Malaria","year":"2016"},{"key":"10.1016\/j.ejmech.2023.115699_bib54","series-title":"PubChem Compound Summary for CID 49856296","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib55","unstructured":"National Institute of Health, U. S. National Library of Medicine, ClinicalTrials.gov, Efficacy, Safety and Tolerability of KAF156 in Combination with Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population with Uncomplicated Plasmodium Falciparum Malaria.."},{"key":"10.1016\/j.ejmech.2023.115699_bib56","series-title":"PubChem Compound Summary for CID 89508529, Unii-VT3A7NA96K","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib57","article-title":"ClinicalTrials.gov, first-in-human study of an oral plasmodium falciparum plasma membrane protein inhibitor","volume":"1","year":"2016","journal-title":"Mar"},{"key":"10.1016\/j.ejmech.2023.115699_bib58","series-title":"PubChem Compound Summary for CID 51347395","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib59","series-title":"ClinicalTrials.gov, DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax","year":"2014"},{"key":"10.1016\/j.ejmech.2023.115699_bib60","series-title":"ClinicalTrials.gov, Safety, Immunogenicity and Efficacy of the Blood-Stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1, December 17","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115699_bib61","series-title":"ClinicalTrials.gov, Safety and Immunogenicity of Pvs25-IMX313\/Matrix-M1 Vaccine","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib62","series-title":"ClinicalTrials.gov, VAC071: A Study to Assess Efficacy of the ChAd63\/MVA PvDBP Vaccines","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115699_bib63","series-title":"ClinicalTrials.gov, PpPfs25\/ISA51 and ScPvs25\/ISA51 Vaccines for Malaria","year":"2006"},{"key":"10.1016\/j.ejmech.2023.115699_bib64","series-title":"ClinicalTrials.gov, Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Native Adults","year":"2010"},{"key":"10.1016\/j.ejmech.2023.115699_bib65","series-title":"ClinicalTrials.gov., Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F (TB31F)","year":"2020"},{"key":"10.1016\/j.ejmech.2023.115699_bib66","series-title":"Triazole Azine Cyclohexylate as LPA Antagonist, Bristol-Myers Squibb Company, JP7208240B2","author":"Shi","year":"2023"},{"key":"10.1016\/j.ejmech.2023.115699_bib67","series-title":"N-triazole-linked Carbamoylcyclohexyl Acids as LPA Antagonists, Bristol Myers Squibb Co., ES2898364T3","author":"Shi","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115699_bib68","series-title":"Hydroxyalkyl Substituted Phenyltriazole Derivatives and Their Uses, Bayer Pharma AG","author":"Shoemaker","year":"2020"},{"key":"10.1016\/j.ejmech.2023.115699_bib69","series-title":"2,4,5- Trisubstituted 1,2,4-triazoles Ketone as DHODH Inhibitor, Bayer Pharma Ag, CN110023302A","author":"Gradl Stefan","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115699_bib70","series-title":"New Pyrazolylpyrimidine Derivatives and Their Use as Malt1 Inhibitors, Novartis AG, CN106170489B","author":"Pisotsodman","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115699_bib71","series-title":"Nd its Use, Qingdao University of Science and Technology, CN106749271B","author":"Huang","year":"2019"},{"key":"10.1016\/j.ejmech.2023.115699_bib72","series-title":"Triazole ACC Inhibitors and Their Use, Gilead Apollo, JP2018536661A","author":"Ghosh","year":"2018"},{"key":"10.1016\/j.ejmech.2023.115699_bib73","series-title":"Pyrazole, Triazole and Tetrazole Orexin Receptor Antagonists, Merck Sharp and Dohme, US10010539B2","author":"Nigel","year":"2018"},{"key":"10.1016\/j.ejmech.2023.115699_bib74","series-title":"Chloroquinoline Triazole Compounds, Composition and Uses, Einstein Coll Med, WO2016111957A1","author":"Schwartz Edward","year":"2016"},{"key":"10.1016\/j.ejmech.2023.115699_bib75","series-title":"Indazolyl Triazole Derivatives as Irak Inhibitors, Merck Serono Sa, EP2655357B1","author":"Catherine","year":"2016"},{"key":"10.1016\/j.ejmech.2023.115699_bib76","series-title":"Triazole Derivatives as Inhibitors of the Vasopressin Receptor for the Treatment of Cardiac Insufficiency, Bayer Intellectual Property Gmbh","author":"Brueggemeier","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115699_bib77","series-title":"1,2,3-Triazole Amide Derivatives as Inhibitors of Cytokine Production, Boehringer Ingelheim Pharma, CA2547410C","author":"Derek","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115699_bib78","series-title":"Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry, Siemens Medical Solutions USA Inc, US8354092B2","author":"Kolb Hartmuth","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115699_bib79","series-title":"Triazole Derivatives for Treating Alzheimer's Disease and Related Conditions, Merck and Co. Inc, Merck Sharp and Dohme Corp, US8242150B2","author":"Fischer","year":"2012"},{"key":"10.1016\/j.ejmech.2023.115699_bib80","unstructured":"Arun R Parikh et al., The Essence of Heterocyclic Chemistry, (Chapter 9), 356-362.."},{"issue":"25","key":"10.1016\/j.ejmech.2023.115699_bib81","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/ejic.202000178","article-title":"Triazole appended phosphines: synthesis, palladium complexes, and catalytic studies","volume":"2020","author":"Mondal","year":"2020","journal-title":"Eur. J. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib83","first-page":"1","article-title":"The 1,2,3-triazole \u2018all-in-one\u2019 ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool","author":"Lengerli","year":"2022","journal-title":"Expet Opin. Drug Discov."},{"issue":"16","key":"10.1016\/j.ejmech.2023.115699_bib84","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2023.115699_bib85","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cmdc.201402233","article-title":"Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups?","volume":"9","author":"Massarotti","year":"2014","journal-title":"ChemMedChem"},{"issue":"13","key":"10.1016\/j.ejmech.2023.115699_bib86","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1021\/acs.chemrev.0c00920","article-title":"Cu (I)-catalyzed click chemistry in glycoscience and their diverse applications","volume":"121","author":"Agrahari","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115699_bib87","series-title":"Key Heterocycle Cores for Designing Multitargeting Molecules","first-page":"323","article-title":"Triazoles: multidimensional 5-membered nucleus for designing multitargeting agents","author":"Kashyap","year":"2018"},{"key":"10.1016\/j.ejmech.2023.115699_bib88","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib89","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/138955711793564051","article-title":"Recent advances and future perspectives of triazole analogs as promising antiviral agents","volume":"11","author":"Kharb","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2023.115699_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104841","article-title":"Design, synthesis and mechanistic study of new 1,2,4-triazole derivatives as antimicrobial agents","volume":"111","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib92","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/1568026621999201214232018","article-title":"CDATA[Recent advances in the development of 1,2,3-Triazole-containing derivatives as potential antifungal agents and inhibitors of lanoster ol 14\u03b1-demethylase","volume":"21","author":"Haroun","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib93","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12906-021-03485-x","article-title":"An in vivo evaluation of anti-inflammatory, analgesic and anti-pyretic activities of newly synthesized 1, 2, 4 Triazole derivatives","volume":"21","author":"Azim","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.ejmech.2023.115699_bib94","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2019.05.045","article-title":"Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: \u03b1-Glucosidase inhibition and glucose uptake promotion","volume":"177","author":"Ye","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115699_bib95","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/acsmedchemlett.8b00109","article-title":"Discovery of natural product derived labdane appended triazoles as potent pancreatic lipase inhibitors","volume":"9","author":"Jalaja","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib96","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bmcl.2010.12.028","article-title":"Triazole incorporated pyridazinones as a new class of antihypertensive agents: design, synthesis and in vivo screening","volume":"21","author":"Siddiqui","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib97","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/1573406418666211110143041","article-title":"1,2,3-Triazole- and quinoline-based hybrids with potent antiplasmodial activity","volume":"18","author":"Graciano","year":"2022","journal-title":"Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib98","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/cbdd.13966","article-title":"A minireview of 1, 2, 3\u2010triazole hybrids with O\u2010heterocycles as leads in medicinal chemistry","volume":"100","author":"Saroha","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"issue":"16","key":"10.1016\/j.ejmech.2023.115699_bib99","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"Vandekerckhove","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bmc.2004.10.010","article-title":"Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety","volume":"13","author":"Khatib","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib101","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ejmech.2017.07.041","article-title":"4-Aminoquinoline-chalcone\/-N-acetylpyrazoline conjugates: synthesis and antiplasmodial evaluation","volume":"138","author":"Kumar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","article-title":"Pyrimidine-chloroquinoline hybrids: synthesis and antiplasmodial activity","volume":"148","author":"Chopra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115699_bib103","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cmdc.201800728","article-title":"Targeting asexual and sexual blood stages of the human malaria parasite P. Falciparum with 7-chloroquinoline-based 1,2,3-triazoles","volume":"14","author":"Wadi","year":"2019","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib104","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jinorgbio.2007.01.006","article-title":"Naturally occurring cobalamins have antimalarial activity","volume":"101","author":"Chemaly","year":"2007","journal-title":"J. Inorg. Biochem."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115699_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24122310","article-title":"Antiplasmodial activity and in vivo bio-distribution of chloroquine molecules released with a 4-(4-ethynylphenyl)-triazole moiety from organometallo-cobalamins","volume":"24","author":"Rossier","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115699_bib106","first-page":"2020","article-title":"Antimalarial properties of isoquinoline derivative from Streptomyces hygroscopicus subsp. hygroscopicus: an in silico approach","author":"Nugraha","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib107","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2019.01.044","article-title":"New hybrid trifluoromethylquinolines as antiplasmodium agents","volume":"27","author":"Silva","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115699_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225276","article-title":"Recent advances in the biological investigation of organometallic platinum-group metal (Ir, Ru, Rh, Os, Pd, Pt) complexes as antimalarial agents","volume":"25","author":"Mbaba","year":"2020","journal-title":"Molecules"},{"issue":"33","key":"10.1016\/j.ejmech.2023.115699_bib109","doi-asserted-by":"crossref","first-page":"11543","DOI":"10.1039\/D0DT01935F","article-title":"Quinoline-triazole half-sandwich iridium(III) complexes: synthesis, antiplasmodial activity and preliminary transfer hydrogenation studies","volume":"49","author":"Melis","year":"2020","journal-title":"Dalton Trans."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm1586","article-title":"Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria","volume":"13","author":"Pamplona","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115699_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111328","article-title":"Diversification of quinoline-triazole scaffolds with CORMs: synthesis, in vitro and in silico biological evaluation against Plasmodium falciparum","volume":"215","author":"Ishmail","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2023.115699_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112889","article-title":"Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions","volume":"209","author":"Huang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104733","article-title":"Synthesis and antiplasmodial evaluation of 1H-1, 2, 3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues","volume":"109","author":"Saini","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib114","series-title":"Biological Evaluation of Novel Side Chain Containing CQTrICh-Analogs as Antimalarials and Their Development as PfCDPK1 Kinase Inhibitors","author":"Irfan","year":"2022"},{"issue":"12","key":"10.1016\/j.ejmech.2023.115699_bib115","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1007\/s00044-022-02975-y","article-title":"Synthesis and in vitro SAR evaluation of natural vanillin-based chalcones tethered quinolines as antiplasmodial agents","volume":"31","author":"Andhare","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115699_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102939","article-title":"Synthesis and systemic toxicity assessment of quinine-triazole scaffold with antiprotozoal potency","volume":"88","author":"Sahu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib117","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","article-title":"4-Aminoquinoline-ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib118","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00508615","article-title":"Pharmacological properties of tetrahydronorharmane (Tryptoline)","volume":"298","author":"Rommelspacher","year":"1977","journal-title":"N. Schmied. Arch. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2023.115699_bib119","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2174\/1389557511313120008","article-title":"Review on in-vitro anti-malarial activity of natural \u03b2-carboline alkaloids","volume":"13","author":"Ashok","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2023.115699_bib120","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1055\/s-0032-1327883","article-title":"In vitro anti-inflammatory effects of beta-carboline alkaloids, isolated from Picrasma quassioides, through inhibition of the iNOS pathway","volume":"78","author":"Zhao","year":"2012","journal-title":"Planta Med."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115699_bib121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1179\/2047773211Y.0000000005","article-title":"Beta-carboline-3-carboxamide derivatives as promising antileishmanial agents","volume":"105","author":"Pedroso","year":"2011","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib122","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1871523019999201111192344","article-title":"In-silico prediction of the beta-carboline alkaloids harmine and harmaline as potent drug candidates for the treatment of Parkinson's disease","volume":"20","author":"Banerjee","year":"2021","journal-title":"Anti-Inflammatory Anti-Allergy Agents Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115699_bib123","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fitote.2010.04.004","article-title":"Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects","volume":"81","author":"Nenaah","year":"2010","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126810","article-title":"Synthesis, anti-plasmodial and cytotoxic evaluation of 1H-1, 2, 3-triazole\/acyl hydrazide integrated tetrahydro-\u03b2-carboline-4-aminoquinoline conjugates","volume":"30","author":"Sharma","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.ejmech.2023.115699_bib125","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.bmc.2016.05.060","article-title":"Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugates","volume":"24","author":"Faidallah","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115699_bib126","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3390\/molecules27092820","article-title":"The shapes of sulfonamides: a rotational spectroscopy study","volume":"27","author":"Vigorito","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115699_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127284","article-title":"Synthesis and characterization of sulfonamide metal complexes as antimicrobial agents","volume":"1202","author":"Pervaiz","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115699_bib128","unstructured":"Mahale, A. and R.S. Abhonkar, The Review on Dapsone. Journal homepage: www.ijrpr.com ISSN. 2582: p. 7421.."},{"issue":"22","key":"10.1016\/j.ejmech.2023.115699_bib129","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.bmcl.2013.09.015","article-title":"Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment","volume":"23","author":"Andrews","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2023.115699_bib130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/1573406417666210604101201","article-title":"Novel dipeptides bearing sulfonamide as antimalarial and antitrypanosomal agents: synthesis and molecular docking","volume":"18","author":"Ekoh","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib131","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejmech.2018.01.082","article-title":"Pyrazole-pyrazoline as promising novel antimalarial agents: a mechanistic study","volume":"149","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.ejmech.2023.115699_bib132","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1021\/acs.jafc.2c00922","article-title":"First discovery of novel cytosine derivatives containing a sulfonamide moiety as potential antiviral agents","volume":"70","author":"Yang","year":"2022","journal-title":"J. Agric. Food Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2023.115699_bib133","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1080\/07391102.2021.1893818","article-title":"Isoleucine with secondary sulfonamide functionality as anticancer, antibacterial and antifungal agents","volume":"40","author":"Devi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115699_bib134","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.3390\/molecules16098083","article-title":"Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes","volume":"16","author":"Boechat","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115699_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03274-w","article-title":"Stable high frequencies of sulfadoxine\u2013pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine\u2013pyrimethamine in Ujjain, Madhya Pradesh, India","volume":"19","author":"Pathak","year":"2020","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ejmech.2023.115699_bib136","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jhet.3888","article-title":"Synthesis, characterization, and antiplasmodial efficacy of sulfonamide\u2010appended [1, 2, 3]\u2010triazoles","volume":"57","author":"Batra","year":"2020","journal-title":"J. Heterocycl. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2023.115699_bib137","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.3390\/molecules25194485","article-title":"A novel series of [1, 2, 4] triazolo [4, 3-a] pyridine sulfonamides as potential antimalarial agents: in silico studies, synthesis and in vitro evaluation","volume":"25","author":"Karpina","year":"2020","journal-title":"Molecules"},{"issue":"34","key":"10.1016\/j.ejmech.2023.115699_bib138","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1002\/slct.201801905","article-title":"Synthesis and antimalarial evaluation of [1, 2, 3]\u2010triazole\u2010tethered sulfonamide\u2010berberine hybrids","volume":"3","author":"Batra","year":"2018","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib139","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eng.2018.11.011","article-title":"Artemisinin, the magic drug discovered from traditional Chinese medicine","volume":"5","author":"Wang","year":"2019","journal-title":"Engineering"},{"key":"10.1016\/j.ejmech.2023.115699_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107658","article-title":"The birth of artemisinin","volume":"216","author":"Ma","year":"2020","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib141","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3347\/kjp.2017.55.6.661","article-title":"Antimalarial activity of C-10 substituted triazolyl artemisinin","volume":"55","author":"Park","year":"2017","journal-title":"Kor. J. Parasitol."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib142","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/molecules27051604","article-title":"An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents","volume":"27","author":"Rubab","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib143","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/14756366.2021.2024526","article-title":"Research progress of coumarins and their derivatives in the treatment of diabetes","volume":"37","author":"Pan","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115699_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/srep13544","article-title":"Coumarin derivatives from Ainsliaea fragrans and their anticoagulant activity","volume":"5","author":"Lei","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051604","article-title":"An update on synthesis of coumarin sulfonamides as enzyme inhibitors and anticancer agents","volume":"27","author":"Rubab","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ejmech.2023.115699_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26051333","article-title":"Coumarin-annulated ferrocenyl 1,3-oxazine derivatives possessing in vitro antimalarial and antitrypanosomal potency","volume":"26","author":"Mbaba","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejmech.2023.115699_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123888","article-title":"Discovery of novel coumarin derivatives as potential dual inhibitors against \u03b1-glucosidase and \u03b1-amylase for the management of post-prandial hyperglycemia via molecular modelling approaches","volume":"27","author":"Patil","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115699_bib148","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2018.01.017","article-title":"In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs","volume":"145","author":"Yadav","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115699_bib149","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00706-021-02821-8","article-title":"Synthesis, antimalarial and antioxidant activity of coumarin appended 1, 4-disubstituted 1, 2, 3-triazoles","volume":"152","author":"Kaushik","year":"2021","journal-title":"Monatshefte f\u00fcr Chemie-Chemical Monthly"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bmc.2016.10.029","article-title":"Synthesis and evaluation of naphthyl bearing 1,2,3-triazole analogs as antiplasmodial agents, cytotoxicity and docking studies","volume":"25","author":"Balabadra","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2023.115699_bib151","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.3390\/molecules24213917","article-title":"Synthesis and antiplasmodial activity of 1, 2, 3-triazole-naphthoquinone conjugates","volume":"24","author":"Oramas-Royo","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2023.115699_bib152","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00044-017-2072-x","article-title":"Convenient synthesis, antimalarial and antimicrobial potential of thioethereal 1,4-disubstituted 1,2,3-triazoles with ester functionality","volume":"27","author":"Kaushik","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115699_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109688","article-title":"1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity","volume":"350","author":"Val\u00e9rio Lopes","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115699_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.sciaf.2021.e00998","article-title":"Synthesis, molecular docking studies and ADME prediction of some new triazoles as potential antimalarial agents","volume":"14","author":"Kekessie","year":"2021","journal-title":"Scientific African"},{"issue":"1","key":"10.1016\/j.ejmech.2023.115699_bib155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00044-022-02994-9","article-title":"1, 2, 3-triazenes and 1, 2, 3-triazoles as antileishmanial, antitrypanosomal, and antiplasmodial agents","volume":"32","author":"Seck","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115699_bib156","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s13738-018-1330-2","article-title":"Design, synthesis, activity evaluation and QSAR studies of novel antimalarial 1, 2, 3-triazolo-\u03b2-lactam derivatives","volume":"15","author":"Jarrahpour","year":"2018","journal-title":"J. Iran. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ejmech.2023.115699_bib157","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/D2MD00085G","article-title":"Thiamine analogues as inhibitors of pyruvate dehydrogenase and discovery of a thiamine analogue with non-thiamine related antiplasmodial activity","volume":"13","author":"Chan","year":"2022","journal-title":"RSC Med Chem"},{"issue":"15","key":"10.1016\/j.ejmech.2023.115699_bib158","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.bmc.2017.05.054","article-title":"1,2,4-Triazole and 1,3,4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities","volume":"25","author":"Thakkar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2023.115699_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081197","article-title":"Plasmodium falciparum knockout for the GPCR-like PfSR25 receptor displays greater susceptibility to 1,2,3-triazole compounds that block malaria parasite development","volume":"10","author":"Santos","year":"2020","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.ejmech.2023.115699_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115762","article-title":"Protease inhibition-an established strategy to combat infectious diseases","volume":"22","author":"Sojka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.ejmech.2023.115699_bib161","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1074\/jbc.REV120.009309","article-title":"Malaria parasite plasmepsins: more than just plain old degradative pepsins","volume":"295","author":"Nasamu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2023.115699_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800151","article-title":"Azole-based non-peptidomimetic plasmepsin inhibitors","volume":"351","author":"Kinena","year":"2018","journal-title":"Arch. Pharm. (Weinheim)"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423006669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:00:19Z","timestamp":1759330819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423006669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":160,"alternative-id":["S0223523423006669"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115699","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115699"}}